ルーマニア -
ルーマニア語 -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
dr. böhm sunatoare 425 mg
apomedica pharmazeutische produkte gmbh - austria - plante (sunatoare) - caps. - 425mg - antidepresive antidepresive
モルドバ -
ルーマニア語 -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
holymet 5 mg/ml soluţie perfuzabilă
holyhead pharmaceuticals private ltd., - metronidazolum - soluţie perfuzabilă - 5 mg/ml
モルドバ -
ルーマニア語 -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
molxvir 200 mg capsule
sun pharmaceutical industries, ltd - molnupiravirum - capsule - 200 mg
モルドバ -
ルーマニア語 -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
novo-passit comprimate filmate
teva pharmaceutical industries ltd - o combinatie - comprimate filmate
欧州連合 -
ルーマニア語 -
EMA (European Medicines Agency)
odomzo
sun pharmaceutical industries europe b.v. - difosfat de sonidegib - carcinomul, celula bazală - agenți antineoplazici - odomzo este indicat pentru tratamentul pacienților adulți cu carcinom bazocelular local avansat (bcc), care nu sunt supuși intervențiilor chirurgicale curative sau radioterapiei.
ルーマニア -
ルーマニア語 -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
vistabel, 4 unitati allergan/0,1 ml
allergan pharmaceuticals ireland ltd. - irlanda - toxina botulinica de tip a unui - pulb. pt. sol. inj. - 4 unitati allergan/0,1ml - miorelaxante periferice alte miorelaxante cu actiune periferica
ルーマニア -
ルーマニア語 -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sunitinib g.l. pharma 12,5 mg
remedica ltd. - cipru - sunitinibum - caps. - 12,5mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
ルーマニア -
ルーマニア語 -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sunitinib g.l. pharma 25 mg
remedica ltd. - cipru - sunitinibum - caps. - 25mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
ルーマニア -
ルーマニア語 -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sunitinib g.l. pharma 50 mg
remedica ltd. - cipru - sunitinibum - caps. - 50mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
欧州連合 -
ルーマニア語 -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenți antineoplazici - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.